The Transition from Pemphigus Foliaceus to Pemphigus Vegetans—An Intriguing Phenomenon within the Spectrum of Autoimmune Blistering Diseases: A Case Report
Olguța Anca Orzan,
Liliana Gabriela Popa,
Iulia Badiu,
Ana Ion,
Călin Giurcăneanu,
Beatrice Bălăceanu-Gurău,
Irina Tudose
Affiliations
Olguța Anca Orzan
Department of Oncologic Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
Liliana Gabriela Popa
Department of Oncologic Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
Iulia Badiu
Department of Oncologic Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
Ana Ion
Department of Oncologic Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
Călin Giurcăneanu
Department of Oncologic Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
Beatrice Bălăceanu-Gurău
Department of Oncologic Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
Irina Tudose
Department of Pathology, Elias University Emergency Hospital, 011461 Bucharest, Romania
Pemphigus vegetans and pemphigus foliaceus are rare autoimmune blistering diseases characterized by the disruption of desmosomal adhesion proteins, particularly desmoglein 3 and desmoglein 1. We report the case of a 62-year-old male who presented initially with scaly red plaques posing several diagnostic challenges. A histopathological examination revealed subcorneal acantholysis, matching the suspected clinical diagnosis of pemphigus foliaceus. The patient progressed, developing vegetating plaques, and a new biopsy was performed. The new histopathological and direct immunofluorescence exams were consistent with pemphigus vegetans. This case highlights the diagnostic challenges posed by the transition of pemphigus foliaceus to its vegetating form. We discuss the role of desmogleins in the pathogenesis of pemphigus and explore potential therapeutic strategies targeting these specific autoantigens.